Subscribe To
Clearside biomedical to report third quarter 2023 financial results and provide corporate update on monday, november 13, 2023
ALPHARETTA, Ga., Oct. 31, 2023 (GLOBE NEWSWIRE) — Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceut...
October 31, 2023, 11:05 am
Bioxcel therapeutics to report third quarter 2023 financial results on november 14, 2023
NEW HAVEN, Conn., Oct. 31, 2023 (GLOBE NEWSWIRE) — BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceu...
October 31, 2023, 11:00 am
Kiniksa pharmaceuticals, ltd. (knsa) reports q3 loss, tops revenue estimates
Kiniksa pharmaceuticals, Ltd. (KNSA) came out with a quarterly loss of $0.20 per share versus the Zacks...
October 31, 2023, 10:32 am
Context therapeutics reveals ‘encouraging' preclinical data for ctim-76 tumor treatment
Context Therapeutics (NASDAQ:CNTX) Inc has announced what it called encouraging preclinical data regarding its preclinical asset, CTIM-76, a Claudin 6...
October 31, 2023, 10:12 am
Fulcrum therapeutics to host third quarter 2023 financial results conference call and webcast on tuesday, november 7, 2023, at 8:00 a.m. et
CAMBRIDGE, Mass., Oct. 31, 2023 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (the “Company”) (Nasdaq: FULC), a clinical-stage bio...
October 31, 2023, 8:50 am
Pph: a 'shot in the arm' for investors looking to capitalize on recent pharmaceutical advances
VanEck pharmaceutical ETF has had the strongest one-year performance of four major ...
October 31, 2023, 3:35 am
Epilepsy therapeutics market predicted to reach usd 14.9 bn by 2031 | exclusive report by transparency market research
Continuous R&D in second- and third-generation anti-epileptic drugs (AEDs) is anticipated to pave the way to new opportunities for ...
October 30, 2023, 9:30 pm
Amphastar pharmaceuticals (amph) laps the stock market: here's why
The latest trading day saw Amphastar pharmaceuticals (AMPH) settling at $45.19, representing a +1.23% c...
October 30, 2023, 7:34 pm
All you need to know about adial pharmaceuticals, inc. (adil) rating upgrade to buy
Adial pharmaceuticals, Inc. (ADIL) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optim...
October 30, 2023, 1:32 pm
Sanofi stock recovers slightly after last week's plunge
Sanofi (SNY) shares are trending higher after plummeting last Friday, after the pharmaceutical company ...
October 30, 2023, 11:39 am
Olema pharmaceuticals, inc. (olma) is a great choice for 'trend' investors, here's why
Olema pharmaceuticals, Inc. (OLMA) could be a great choice for investors looking to make a profit from ...
October 30, 2023, 10:33 am
Deciphera pharmaceuticals, inc. (dcph) reports q3 loss, tops revenue estimates
Deciphera pharmaceuticals, Inc. (DCPH) came out with a quarterly loss of $0.58 per share versus the Zac...
October 30, 2023, 9:46 am
Nexgel announces supply agreement with abbvie
NEXGEL (NASDAQ:NXGL) announced that its CG Converting and Packaging subsidiary has executed a supply agreement with bio...
October 30, 2023, 8:51 am
Why is conduit pharmaceuticals (cdt) stock up 66% today?
Conduit pharmaceuticals (NASDAQ: CDT ) stock is rocketing higher on Monday despite a lack of news from...
October 30, 2023, 8:39 am
Calibre scientific acquires cps analitica, a provider of chromatography consumables in italy
LOS ANGELES, Oct. 30, 2023 (GLOBE NEWSWIRE) — Calibre Scientific is pleased to announce the acquisition of C.P.S. Analitica S.r.l. (“CPS” or the...
October 30, 2023, 8:00 am
Reviva pharma's schizophrenia drug succeeds in late-stage study
Reviva pharmaceuticals Holdings said on Monday its experimental drug to treat adults with schizophrenia...
October 30, 2023, 7:41 am
Kura oncology to participate in three upcoming investor conferences
SAN DIEGO, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceu...
October 30, 2023, 7:30 am
Neumora therapeutics to participate in upcoming conferences in november
WATERTOWN, Mass., Oct. 30, 2023 (GLOBE NEWSWIRE) -- Neumora Therapeutics, Inc. (Nasdaq: NMRA), a clinical-stage bio...
October 30, 2023, 7:00 am
Eton pharmaceuticals to report third quarter 2023 financial results on thursday, november 9, 2023
DEER PARK, Ill., Oct. 30, 2023 (GLOBE NEWSWIRE) -- Eton pharmaceuticals, Inc. (Nasdaq: ETON), an innova...
October 30, 2023, 6:50 am
Fennec pharmaceuticals to report third quarter 2023 financial results on november 6, 2023
RESEARCH TRIANGLE PARK, N.C., Oct. 30, 2023 (GLOBE NEWSWIRE) -- Fennec pharmaceuticals Inc. (NASDAQ: FE...
October 30, 2023, 6:45 am